Atlas Trials

Chemoradiotherapy for Patients With Locally Advanced Nasopharyngeal Carcinoma Using Raltitrexed-Cisplatin

Clinical trial NCT02562599 · COMPLETED

Trial details

NCT number
NCT02562599
Sponsor
Hubei Cancer Hospital
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Nasopharyngeal Carcinoma
Start date
2015-08-01
Primary completion
2016-12-01
Enrollment
60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.